The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nationwide real-world usage of blood-based (liquid) biomarker testing in Japan.
 
Yasushi Yatabe
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Chugai Pharma; Daiichi Sankyo/UCB Japan; MSD K.K
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; MSD K.K
Research Funding - Konica Minolta; Merck; Thermo Fisher Scientific
 
Daisuke Ennishi
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Eisai; Kyowa Kirin; Nippon Shinyaku; SymBio Pharmaceuticals
Consulting or Advisory Role - MSD
Research Funding - Chugai Pharma; Eisai Pharmaceutical Co., Ltd.; Nipponshinyaku Pharmaceutical Co., Ltd.
 
Yuko Kotera
Employment - Merck Sharp & Dohme; Pfizer (I)
Stock and Other Ownership Interests - Takeda; Takeda (I)
 
Ryosuke Watanabe
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme